NDC codes

FDA NDC Directory
Product NDC (as listed)0574-0611Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00574-0611Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0574-0611-05005740611051 BOTTLE, GLASS in 1 CARTON (0574-0611-05) / 3.5 mL in 1 BOTTLE, GLASSMarketed from Jan 29, 2002

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Podofilox
Generic name (nonproprietary)
podofilox
Active ingredients
Podofilox — 5 mg/mL
Dosage form
Solution
Route
Topical
Labeler
Padagis US LLCNDC labeler code 0574
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 075600
Marketing start
Listing expires
Other FDA classes
Decreased Mitosis (Physiologic effect)
Identifiers
Product ID 0574-0611_e75d3f9f-dd11-4c3e-9e6e-3d9af2cd76daSPL ID e75d3f9f-dd11-4c3e-9e6e-3d9af2cd76daSPL set ID 6af07697-5203-43e0-ba35-83683af851c3RxCUI 582926UNII L36H50F353

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400574061105 followed by a unit qualifier and the quantity

Package 00574-0611-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Podofilox Topical Solution 0.5% is indicated for the topical treatment of external genital warts (Condyloma acuminatum). This product is not indicated in the treatment of perianal or mucous membrane warts (see PRECAUTIONS ). Diagnosis Although genital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. Differentiating warts from squamous cell carcinoma (so-called "Bowenoid papulosis") is of particular concern. Squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with Podofilox Topical Solution 0.5%.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0574-0611

What is NDC 0574-0611?
0574-0611 is the product NDC for Podofilox, Podofilox 5 mg/mL solution, listed with the FDA by Padagis US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Podofilox.
What is the active ingredient?
Podofilox.
Who is the labeler?
Padagis US LLC, NDC labeler code 0574. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Podofilox?
1 other product NDC are listed under this name. See all Podofilox NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Podofilox NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
PodofiloxPodofilox 5 mg/gGelTopicalPadagis US LLC0574-062100574-0621-05

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in